CHD Chemicals is a trading and distribution firm that sources industrial chemicals and dyes from large manufacturers like Huntsman International to sell to textile, leather, and paper producers.
The company operates as a pure middleman in a highly fragmented and competitive commodity trading market. Financial metrics show negative net margins and a total lack of pricing power, as evidenced by a 31% revenue decline and an inability to maintain profitability despite lower volumes.
Capital allocation is poor, characterized by a failure to generate returns on reinvestment and a reliance on interest-free advances to employees and related parties while the core business shrinks. The company has high debt relative to its earnings capacity and negative interest coverage.
The business collapsed as the shrinking revenue base finally failed to cover fixed costs, leading to a liquidity crisis. The observed practice of funneling interest-free advances to employees and related parties while the core business bled cash eventually exhausted the company's remaining capital. Regulatory authorities likely intervened following years of chronic filing delays and non-compliant director qualifications, resulting in a total loss of market access and a delisting that wiped out minority shareholders.
RichFakir rates CHD Chemicals Ltd's business quality as poor — 18/100 on our quality score (profitability, growth, balance-sheet strength and capital allocation). We assess its competitive moat as none.
On our model, CHD Chemicals Ltd is trading far above our estimate of fair value (expensive on our lens); we rate its price expensive. This is an educational estimate from public filings, not a recommendation.
RichFakir's educational verdict on CHD Chemicals Ltd is: Avoid. We are steering clear of this one — the red flags below outweigh anything the price or numbers offer.
RichFakir's educational estimate of CHD Chemicals Ltd's fair value is about ₹2 per share, derived from public filings. It's our estimate for research — not a price target or a recommendation to buy or sell.
View the full live analysis →